2016
DOI: 10.1080/08923973.2016.1214143
|View full text |Cite
|
Sign up to set email alerts
|

Effects of insulin on pharmacodynamics of immunosuppressive drugs against mitogen-activated human peripheral blood mononuclear cells

Abstract: These results indicate that insulin at even physiological concentration attenuates suppressive efficacies of several immunosuppressive drugs against mitogen-activated proliferation of human PBMCs, possibly via insulin receptors. Insulin used in dialysis patients accompanying diabetes mellitus is suggested to attenuate efficacies of immunosuppressive drugs after renal transplantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…In this assay, adapted from Chen et al 2016 [45], PBMCs from 2 different donors, were seeded at 10 6 cells/mL in C-10 medium (RPMI 1640 without phenol red, +10% FBS (Corning, Corning, NY, USA), +1% P/S (Gibco-BRL), +0.1% β-mercaptoethanol (Gibco-BRL, Waltham, MA, USA), +0.1% sodium pyruvate (Gibco-BRL, Waltham, MA, USA), +0.1% sodium bicarbonate (Gibco-BRL, Waltham, MA, USA) and stimulated with 100 pg/mL of LPS. Cells were treated/stimulated in the same way as in the previous assay, with the same test groups and controls but the assay was kept for 96 h. After 96 h, 10 µL/well of an aqueous solution (5 mg/mL) of tetrazolium blue (Merk, Darmstadt, Germany) was added.…”
Section: Mtt Assaymentioning
confidence: 99%
“…In this assay, adapted from Chen et al 2016 [45], PBMCs from 2 different donors, were seeded at 10 6 cells/mL in C-10 medium (RPMI 1640 without phenol red, +10% FBS (Corning, Corning, NY, USA), +1% P/S (Gibco-BRL), +0.1% β-mercaptoethanol (Gibco-BRL, Waltham, MA, USA), +0.1% sodium pyruvate (Gibco-BRL, Waltham, MA, USA), +0.1% sodium bicarbonate (Gibco-BRL, Waltham, MA, USA) and stimulated with 100 pg/mL of LPS. Cells were treated/stimulated in the same way as in the previous assay, with the same test groups and controls but the assay was kept for 96 h. After 96 h, 10 µL/well of an aqueous solution (5 mg/mL) of tetrazolium blue (Merk, Darmstadt, Germany) was added.…”
Section: Mtt Assaymentioning
confidence: 99%
“…First, to test in vitro safety, an MTT-type assay was performed on THP-1 cells transformed to macrophages by adapting the method of Chen et al in 2016 [30]. Differentiated THP-1 cells were washed three times with 0.2 mL of tempered THP-1 medium without PMA and allowed to rest for 30 min before LPS stimuli.…”
Section: Thp-1 In Vitro Inflammation Modelmentioning
confidence: 99%
“…To test the possible in vitro immunogenicity reaction, an MTTtype assay was performed on macrophage-transformed THP-1 cells by adapting the method of Chen et al [22]. Differentiated THP-1 cells were washed three times with 0.2mL of tempered THP-1 medium without PMA and allowed to stand for 30min before LPS…”
Section: Mtt Assay (3-(34 -Dimethylthiazol-2-thiazolyl)-25diphenyltet...mentioning
confidence: 99%